Skip to main content
. Author manuscript; available in PMC: 2017 Apr 12.
Published in final edited form as: Clin Genet. 2016 Jan 20;89(5):539–549. doi: 10.1111/cge.12711

Table 3.

Integration of clinical and laboratory information for patients with classical CF (N = 300), CFTR-RD (N = 19), and CRMS (N = 57)

Disease type Symptoms Sweat chloridea IRT CFTR mutation class Pancreatic status FTT Colonizationb
CF + Majority >60 mmol/l I–IIIc >80% insufficient >25% >80% PA > 20% MRSA
CFTR-RD + Majority <60 mmol/l IV–V Sufficient ~20% <35% PA 0% MRSA
CRMS All <60 mmol/l IV–V Sufficient ~2% <40% PA < 5% MRSA

CF, cystic fibrosis; CFTR-RD, cystic fibrosis transmembrane regulator-related disease; CRMS, cystic fibrosis transmembrane regulator-related metabolic syndrome; FTT, failure to thrive; IRT, immunoreactive trypsinogen; MRSA, methicillin-resistant Staphylococcus aureus; PA, Pseudomonas aeruginosa.

a

Sweat chloride measurements are report.

b

Microbiological growth on oropharyngeal, sputum, and/or bronchoalveolar lavage specimens from the time poinst closest to diagnosis.

c

Exceptions noted in manuscript text.